These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23835618)

  • 41. Functional significance of the hepaCAM gene in bladder cancer.
    He Y; Wu X; Luo C; Wang L; Lin J
    BMC Cancer; 2010 Mar; 10():83. PubMed ID: 20205955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.
    Jiang Y; Han Y; Sun C; Han C; Han N; Zhi W; Qiao Q
    Tumour Biol; 2016 Jun; 37(6):8131-8. PubMed ID: 26715272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line.
    Ou L; Guo Y; Luo C; Wu X; Zhao Y; Cai X
    Cancer Genet Cytogenet; 2010 Jul; 200(2):110-9. PubMed ID: 20620593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
    Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
    Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells.
    Kim CJ; Yoshioka N; Tambe Y; Kushima R; Okada Y; Inoue H
    Int J Cancer; 2005 Oct; 117(1):51-8. PubMed ID: 15880581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation.
    Sun Y; Cheng MK; Griffiths TR; Mellon JK; Kai B; Kriajevska M; Manson MM
    Curr Cancer Drug Targets; 2013 Jan; 13(1):57-68. PubMed ID: 22920439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.
    Avgeris M; Mavridis K; Tokas T; Stravodimos K; Fragoulis EG; Scorilas A
    Carcinogenesis; 2015 May; 36(5):528-37. PubMed ID: 25804644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of novel piRNAs in bladder cancer.
    Chu H; Hui G; Yuan L; Shi D; Wang Y; Du M; Zhong D; Ma L; Tong N; Qin C; Yin C; Zhang Z; Wang M
    Cancer Lett; 2015 Jan; 356(2 Pt B):561-7. PubMed ID: 25305452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Gui Y; Cai Z
    J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.
    Lee EJ; Lee SJ; Kim S; Cho SC; Choi YH; Kim WJ; Moon SK
    Cell Signal; 2013 Oct; 25(10):2025-38. PubMed ID: 23770289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pattern of somatostatin receptors expression in normal and bladder cancer tissue samples.
    Karavitakis M; Msaouel P; Michalopoulos V; Koutsilieris M
    Anticancer Res; 2014 Jun; 34(6):2937-42. PubMed ID: 24922657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells.
    Li Z; Zhu Y; Yu M; Ji D; Yang Z; Kong C
    Urol Oncol; 2013 Feb; 31(2):228-33. PubMed ID: 21872498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer.
    Marín-Aguilera M; Mengual L; Ribal MJ; Ars E; Ríos J; Gázquez C; Villavicencio H; Alcaraz A
    Urology; 2012 Jan; 79(1):240.e9-15. PubMed ID: 22055693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
    Zhu H; Yun F; Shi X; Wang D
    Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
    Zheng Y; Izumi K; Yao JL; Miyamoto H
    Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma.
    Gunes S; Sullu Y; Yegin Z; Buyukalpelli R; Tomak L; Bagci H
    Pathol Res Pract; 2013 Feb; 209(2):99-104. PubMed ID: 23333248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma T24 cells.
    Dufresne M; Dumas G; Asselin E; Carrier C; Pouliot M; Reyes-Moreno C
    Mol Immunol; 2011 Jul; 48(12-13):1556-67. PubMed ID: 21601924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion.
    Ding Y; Wang G; Ling MT; Wong YC; Li X; Na Y; Zhang X; Chua CW; Wang X; Xin D
    Int J Oncol; 2006 Apr; 28(4):847-54. PubMed ID: 16525633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase.
    Li Y; Yang K; Mao Q; Zheng X; Kong D; Xie L
    Int Urol Nephrol; 2010 Jun; 42(2):315-23. PubMed ID: 19669587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.